Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Moleculin Biotech, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 22 | 25 | +3 |
| Shares | 389.7K | 778.3K | +388.6K (+99.7%) |
| Value | $117.9K | $412.7K | +$294.8K (+250.0%) |
New holders (8)
Institutions that held Moleculin Biotech, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 115,190 | $61.0K | 0.00% |
| Ieq Capital, LLC | 36,363 | $19.3K | 0.00% |
| Wealth Dimensions Group, Ltd. | 20,000 | $10.6K | 0.00% |
| Rockefeller Capital Management L.P. | 14,506 | $7.69K | 0.00% |
| Goldman Sachs Group Inc | 12,752 | $6.76K | 0.00% |
| Ethos Financial Group, LLC | 10,034 | $5.32K | 0.00% |
| Moors & Cabot, Inc. | 10,000 | $5.30K | 0.00% |
| NBC Securities, Inc. | 14 | $7 | 0.00% |
Sold out (5)
Institutions that held Moleculin Biotech, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citigroup Inc | 85,283 | $25.7K |
| XTX Topco Ltd | 74,217 | $22.4K |
| Virtu Financial LLC | 59,278 | $18.0K |
| Stone House Investment Management, LLC | 3,300 | $996 |
| Atlantic Union Bankshares Corp | 379 | $115 |